These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20166103)

  • 41. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
    Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
    Schenk JM; Till C; Hsing AW; Stanczyk FZ; Gong Z; Neuhouser ML; Reichardt JK; Hoque AM; Figg WD; Goodman PJ; Tangen CM; Thompson IM
    Cancer Causes Control; 2016 Feb; 27(2):175-82. PubMed ID: 26589415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasectomy and prostate cancer: results from a multiethnic case-control study.
    John EM; Whittemore AS; Wu AH; Kolonel LN; Hislop TG; Howe GR; West DW; Hankin J; Dreon DM; Teh CZ
    J Natl Cancer Inst; 1995 May; 87(9):662-9. PubMed ID: 7538594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.
    Kaaks R; Lukanova A; Rinaldi S; Biessy C; Söderberg S; Olsson T; Stenman UH; Riboli E; Hallmans G; Stattin P
    Eur J Cancer Prev; 2003 Aug; 12(4):309-15. PubMed ID: 12883384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
    Janssen JA; Wildhagen MF; Ito K; Blijenberg BG; Van Schaik RH; Roobol MJ; Pols HA; Lamberts SW; Schröder FH
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4391-6. PubMed ID: 15356036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
    Lukanova A; Becker S; Hüsing A; Schock H; Fedirko V; Trepo E; Trichopoulou A; Bamia C; Lagiou P; Benetou V; Trichopoulos D; Nöthlings U; Tjønneland A; Overvad K; Dossus L; Teucher B; Boeing H; Aleksandrova K; Palli D; Pala V; Panico S; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Quiros JR; Duell EJ; Molina-Montes E; Chirlaque MD; Gurrea AB; Dorronsoro M; Lindkvist B; Johansen D; Werner M; Sund M; Khaw KT; Wareham N; Key TJ; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Jenab M; Kaaks R
    Int J Cancer; 2014 Jan; 134(1):164-73. PubMed ID: 23801371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
    J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
    J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ
    Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.
    Yu H; Nicar MR; Shi R; Berkel HJ; Nam R; Trachtenberg J; Diamandis EP
    Urology; 2001 Mar; 57(3):471-5. PubMed ID: 11248622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate cancer risk and serum levels of insulin and leptin: a population-based study.
    Hsing AW; Chua S; Gao YT; Gentzschein E; Chang L; Deng J; Stanczyk FZ
    J Natl Cancer Inst; 2001 May; 93(10):783-9. PubMed ID: 11353789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
    Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC
    Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.